Accenture (NYSE:ACN) has agreed to acquire COMWARE Co., Ltd., a Tokyo-based provider of end-to-end technology services for mid-market companies. The acquisition will further strengthen Accenture Edge, a new business entity launched in June 2026 to help mid-market companies harness AI and reinvent how they operate. Terms of the transaction were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825513852/en/COMWARE Co., Ltd. to become part of Accenture COMWARE is recognized for its strong IT implementation and operations capabilities for mid-market, as well as for its expertise in SAP and CRM technologies. COMWARE w
Live Feed
Delayed 3mPress · Analyst · Insider · SEC · FDA
Signed out · 3-min delay · Sign up for real-time
- Accenture to Acquire COMWARE to Strengthen Accenture Edge and Accelerate Digital Core Reinvention for Mid-Market Companies in Japan
- Gaotu Techedu Announces Second Quarter 2026 Unaudited Financial Results
BEIJING, Aug. 27, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE:GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong learning through AI-powered solutions, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights[1]Net revenues were RMB1,670.1 million, increased by 20.2% from RMB1,389.4 million in the same period of 2025.Gross billings[2] were RMB2,689.1 million, increased by 19.4% from RMB2,252.4 million in the same period of 2025.Loss from operations was RMB149.8 million, compared with loss from operations of RMB241.9 million in the same period of 2025.Net loss
- Digital Realty breaks ground on new state-of-the-art data center in Switzerland
ZURICH, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE:DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced the start of construction on a new, state-of-the-art data center in Glattbrugg. The facility – ZUR4 – will provide 15 megawatts (MW) of IT capacity across approximately 6,300 m2 of space, serving the growing demand for digital infrastructure in one of Europe's most important data and financial hubs. ZUR4 is planned to expand the already best-connected data center campus in Switzerland, comprising ZUR1, ZUR2, and ZUR3. Digital Realty's entire European portfolio, including its data centers in Switzerland, is powered by 100% renewable energ
- AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
Submission supported by data from Phase 3 pivotal AFFIRM study If approved, adult Crohn's disease patients will have an additional option for induction of risankizumab which is already approved for intravenous (IV) inductionNORTH CHICAGO, Ill., Aug. 27, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that it has submitted an application to the European Medicines Agency (EMA) seeking approval for SKYRIZI® (risankizumab) for subcutaneous (SC) induction for the treatment of adult patients with moderately to severely active Crohn's disease (CD). The application to the EMA is supported by the recently shared positive data from the Phase 3 AFFIRM study1 (NCT06063967), which evaluated the e
- TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
Statistically Significant and Clinically Meaningful Disease and Symptom Improvements Compared to Placebo Maintained Through Week 52Efficacy in a Third Epithelial-Driven Inflammatory Disease Supports Broad Potential of TEZSPIRE THOUSAND OAKS, Calif., Aug. 27, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 CROSSING trial of TEZSPIRE® (tezepelumab-ekko) in patients living with eosinophilic esophagitis (EoE). TEZSPIRE demonstrated statistically significant and clinically meaningful improvements across co-primary and key secondary endpoints at week 24 which were sustained through week 52. The co-primary endpoints were histologic
- CMB.TECH ANNOUNCES Q2 2026 RESULTS
ANTWERP, Belgium, 27 August 2026 – CMB.TECH NV ("CMBT", "CMB.TECH" or "the company") (NYSE:CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO)) reported its unaudited financial results today for the second quarter ended 30 June 2026. HIGHLIGHTSFinancial highlights: Profit for the period of USD 364.4 million in Q2 2026. EBITDA for the same period was USD 552.8 million.CMB.TECH’s contract backlog stable at USD 3.26 billion with the addition of 2 x 2-year CSOV time charters and 1 x 1-year VLCC time charterIntention to distribute an amount of USD 0.64 per share. Fleet highlights: Delivery of 9 newbuilding vessels (Q2 + Q3 to date): Newcastlemaxes: Mineral Latvija, Mineral Magyar,
- Materialise Reports Second Quarter and Half-Year 2026 Results
Regulated information1 Materialise NV ((Euronext &, NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased by 15.7% to 9,593 kEUR for the second quarter of 2026 compared to 8,288 kEUR for the second quarter of 2025. Adjusted EBIT increased by 26.9% to 3,880 kEUR for the second quarter of 2026 from 3,058 kE
- Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ("Jazz Pharmaceuticals") announced the pricing of $1.1 billion aggregate principal amount of 1.875% exchangeable senior notes due 2032 (the "notes") in a private offering (the "offering") by Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously announced offering size of $1.0 billion aggregate principal amount of notes. The Issuer also granted the initial purchasers of the notes the right to purchase, exercisable within a 13-day pe
- IBM Study: Canadian Sports Fans Expect More From the Fan Experience as AI Reshapes Sports
Fans want faster recaps, more personalized experiences and easier ways to keep up with their favourite sports, teams and players68% of surveyed Canadian sports fans see value in AI-powered sports features44% say managing multiple sports subscriptions is frustrating54% want faster event recaps52% want more access to favourite players and teamsMARKHAM, ON, Aug. 27, 2026 /CNW/ -- Canadian sports fans are embracing AI-powered features, streaming platforms and sports apps, according to new online survey research commissioned by IBM (NYSE:IBM). As technology becomes a bigger part of sports fandom, fans are raising their expectations and demanding faster access, more personalized experiences and ea
- PRIMERICA HOUSEHOLD BUDGET INDEX™ (HBI™): Purchasing Power for Middle-Income Americans Up Slightly in July
The latest Primerica Household Budget Index™ (HBI™) data, a monthly economic metric that examines how inflation and wage trends impact the ability of middle-income families to afford life’s everyday necessities, is estimated at 100.5% in July, an increase of 0.4% from June and also up 0.4% from a year ago. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826011714/en/The latest Primerica Household Budget Index™ (HBI™) data, a monthly economic metric that examines how inflation and wage trends impact the ability of middle-income families to afford life’s everyday necessities, is estimated at 100.5% in July, an increase of 0.4% f
- Faraday Future Announces Execution Roadmap for Its “Built in USA” Acceleration Program and Launches Distributor Recruitment; Targets to Bring Its Robot Factory Online by Year-End and First New EAI Device Product Off the Line in February 2027
Numerous announcements made today as FF holds Part One of its FF EAI Robotics "Built in USA" Business Partner Conference, highlighting—the "Four-Core Full-Stack AI" Ecosystem Downstream Partner recruitment and the EAI Education Ecosystem milestone showcase & nationwide expansion session. FF announced that its first two new EAI Devices selected for the "Built in USA" program are the full-size humanoid Next Futurist and the quadruped Next Aegis. FF will also officially launch several new additions to the FF EAI Robot World on September 19. FF announced upgrades to its EAI robotics education ecosystem and has completed the initial development of version 1.0 of FF’s Industry Productivity
- SEC Form 4 filed by Large owner Aljomaih Automotive Co.
4 - Xos, Inc. (0001819493) (Issuer)
- Director Jiang Xiao converted options into 5,825 shares and sold $7,056 worth of shares (2,529 units at $2.79) (SEC Form 4) (tax withholding)
4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)
- Executive Chairman Wang Jiawei converted options into 13,105 shares and sold $13,830 worth of shares (4,957 units at $2.79), increasing direct ownership by 11,476% to 8,219 units (SEC Form 4) (tax liability)
4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)
- Global CEO Jia Yueting converted options into 21,842 shares and sold $23,051 worth of shares (8,262 units at $2.79), increasing direct ownership by 383% to 17,126 units (SEC Form 4) to cover withholding tax
4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)
- Chief Financial Officer Meka Koti Reddy converted options into 6,699 shares and sold $8,116 worth of shares (2,909 units at $2.79), increasing direct ownership by 9,718% to 3,829 units (SEC Form 4) (tax liability)
4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)
- SEC Form 4 filed by Director Pappis Charles C
4 - ACM Research, Inc. (0001680062) (Issuer)
- SEC Form 4 filed by Director Liu Tracy
4 - ACM Research, Inc. (0001680062) (Issuer)
- SEC Form 4 filed by Director Dun Haiping
4 - ACM Research, Inc. (0001680062) (Issuer)